3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Mazindol: new trials by email Literature Review of Mazindol trials Research Report on Mazindol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy Mazindol - Narcolepsy With Cataplexy, Narcolepsy | Phase 2 | Completed | NLS Pharmaceutics | 52 | 2021-10-26 | 2023-03-13 |
| Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD) mazindol - Attention Deficit Disorder With Hyperactivity | Phase 2 | Completed | NLS Pharmaceutics | 84 | 2016-08-01 | 2017-04-06 |
| Mazindol for Cocaine Abuse - 2 Mazindol - Cocaine-Related Disorders | Phase 2 | Completed | Yale University | 1994-09-01 | 2020-06-18 |
Attention Deficit Disorder with Hyperactivity (1) · Cocaine-Related Disorders (1) · Narcolepsy (1)
NLS Pharmaceutics (2) · Yale University (1)
United States (3)
Carlos Camozzi, MD (1) · Thomas R Kosten, M.D. (1)
P50DA009250 (1)